CYP19 genetic polymorphism haplotype AASA is associated with a poor prognosis in premenopausal women with lymph node-negative, hormone receptor-positive breast cancer.
about
Polymorphisms of ESR1, UGT1A1, HCN1, MAP3K1 and CYP2B6 are associated with the prognosis of hormone receptor-positive early breast cancer.The CYP19 RS4646 polymorphism IS related to the prognosis of stage I-II and operable stage III breast cancerAssociations between CYP19A1 polymorphisms, Native American ancestry, and breast cancer risk and mortality: the Breast Cancer Health Disparities StudyGenetic polymorphism at Val80 (rs700518) of the CYP19A1 gene is associated with body composition changes in women on aromatase inhibitors for ER (+) breast cancer.S4646 polymorphism in CYP19A1 gene is associated with the efficacy of hormone therapy in early breast cancer.The rs4646 and rs12592697 Polymorphisms in CYP19A1 Are Associated with Disease Progression among Patients with Breast Cancer from Different Racial/Ethnic Backgrounds.Rs1008805 polymorphism of CYP19A1 gene is associated with the efficacy of hormone therapy in stage I-II and operable stage III breast cancer.Elevated Aromatase (CYP19A1) Expression Is Associated with a Poor Survival of Patients with Estrogen Receptor Positive Breast Cancer.
P2860
Q33591401-E5744F23-0C03-48E3-B7F2-CB569FA2D59BQ35202833-00774AC4-4B42-475C-93D6-9C3CD918150CQ35619090-51362A26-3B43-4DA0-AED2-CF94B438EBCBQ35842073-48B1064D-5B2F-406A-BC9C-044D7E60CD21Q35854143-3B436CBE-BC96-4778-9713-7481E40A970CQ37463634-AB7E89FA-53AE-4992-A3CF-CF16F34AEA95Q44502008-AAC3E27F-8F49-4B70-AAD8-9FE112CD86D8Q48179087-2D817E0C-02A2-4FE1-AB59-2D8F070BA0A7
P2860
CYP19 genetic polymorphism haplotype AASA is associated with a poor prognosis in premenopausal women with lymph node-negative, hormone receptor-positive breast cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
CYP19 genetic polymorphism hap ...... ceptor-positive breast cancer.
@en
CYP19 genetic polymorphism hap ...... ceptor-positive breast cancer.
@nl
type
label
CYP19 genetic polymorphism hap ...... ceptor-positive breast cancer.
@en
CYP19 genetic polymorphism hap ...... ceptor-positive breast cancer.
@nl
prefLabel
CYP19 genetic polymorphism hap ...... ceptor-positive breast cancer.
@en
CYP19 genetic polymorphism hap ...... ceptor-positive breast cancer.
@nl
P2093
P2860
P50
P356
P1476
CYP19 genetic polymorphism hap ...... ceptor-positive breast cancer.
@en
P2093
King-Jeng Chang
Shi-Yi Yang
Yen-Sen Lu
P2860
P304
P356
10.1155/2013/562197
P407
P577
2013-11-14T00:00:00Z